Prevalence and pattern of antinuclear autoantibodies in 347 patients with non-Hodgkin's lymphoma

British Journal of Haematology

Volumn 123, Issue 1, 2003, Pages 90-99

  Guyomard, Stephanie ^a   Salles, Gilles ^a   Coudurier, Marie ^a   Rousset, Hugues ^a   Coiffier, Bertrand ^a   Bienvenu, Jacques ^a   Fabien, Nicole ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Antinuclear autoantibodies; Autoimmune disease; HEp2 cells; Indirect immunofluorescence technique; Non Hodgkin's lymphoma

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLICULAR LYMPHOMA; HEP 2 CELL; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOBLOTTING; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 0141707700     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04587.x     Document Type: Article

References (62)

1. Abu-Shajran, M., Buskila, D., Ehrenfeld, M., Conrad, K. & Shoenfeld, Y. (2001) Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Annals of Rheumatic Disease, 60, 433-441.
2. Adams, B.B. & Mutasim, D.F. (2000) (2000) The diagnostic value of anti-nuclear antibody testing. International Journal of Dermatology, 39, 887-891.
3. Ansell, S.M., Grant, C.S. & Habermann, T.M. (1999) Primary thyroid lymphoma. Seminars in Oncology, 26, 316-323.
4. Antoine, J.C. & Honnorat, J. (2000) Anti-neuronal antibodies and central nervous system diseases, contribution to diagnosis and pathophysiology. Review of Neurology, 156, 23-33.
5. Aozasa, K., Inoue, A., Tajima, K., Miyauchi, A., Matsuzuka, F. & Kuma, K. (1986) Malignant lymphomas of the thyroid gland. Analysis of 79 patients with emphasis on histologic prognostic factors. Cancer, 58, 100-104.
6. Aozasa, K., Ueda, T., Katagiri, S., Matsuzuka, F., Kuma, K. & Yonezawa, T. (1987) Immunologic and immunohistologic analysis of 27 cases with thyroid lymphomas. Cancer, 60, 969-973.
7. Asherson, R.A., Block, S., Houssiau, F.A. & Hughes, G.R. (1991) Systemic lupus erythematosus and lymphoma: association with antiphospholipid syndrome. Journal of Rheumatology, 8, 277-279.
8. Barrios, Y., Plaza, A., Cabrera, R. & Diaz-Espada, F. (2000) Autoantibody activity of the immunoglobulin secreted by a follicular B-cell lymphoma. Acta Pathologica, Microbiologica et Immunologica. 108, 764-770.
9. Beaufay, H., Amar Costesec, A., Feytmans, E., Thines Sempoux, D., Wibo, M., Robbi, M. & Berthet, J. (1974) Analytical study of microsomes and subcellular membranes from rat liver. I. Biochemical methods. Journal of Cell Biology, 61, 188-200.
10. Blaes, F., Klotz, M., Huwer, H., Straub, U., Kalweit, G., Schimrigk, K. & Schafers, H.J. (2000) Antineural and antinuclear autoantibodies are of prognostic relevance in non-small cell lung cancer. Annals of Thoracic Surgery, 69, 254-258.
11. Borche, L., Lim, A., Binet, J.L. & Dighiero, G. (1990) Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. Blood, 76, 562-569.
12. Casiano, C.A., Humbel, R.L., Peebles, C., Covinil G. & Tan, E.M. (1995) Autoimmunity to the cell cycle-dependent centromere protein p330d/CENP-F in disorders associated with cell proliferation. Journal of Autoimmunity, 84, 575-586.
13. Chandor, S.B. (1988) Autoimmune phenomena in lymphoid malignancies. Clinical Laboratory Medicine, 8, 373-384.
14. Chen, T.R. (1988) Re-evaluation of HeLa, HeLa S3, and HEp-2 karyotypes. Cytogenetics and Cell Genetics, 48, 19-24.
15. Dighiero, G. (1998) Autoimmunity and B-cell malignancies. Hematology and Cell Therapy, 40, 1-9.
16. Disis, M.L. & Cheerer, M.A. (1996) Oncogenic proteins as tumor antigens. Current Opinion in Immunology, 8, 637-642.
17. Duhrsen, U., Augener, W., Zwingers, T. & Brittinger, G. (1987) Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases. British Journal of Haematology, 67, 235-239.
18. Fabien, N., Moreira, A., Lavergne, J.P., Reboud, J.P., Desbos, A., Perrier, H., Venot, A., Bargis, P., Vard, C., Bienvenu, J. & Monier, J.C. (1999) Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the PO, P1 and P2 proteins. Journal of Autoimmunity, 13, 103-110.
19. Fernandez-Madrid, F. & Tomkiel, J. (2000) Antinuclear antibodies as potential markers of lung cancer. In: Cancer and Autoimmunity (ed. by Y. Shoenfeld & M.E. Gershwin), pp. 151-158. Elsevier Science.
20. Fleischmann, M., Celerier, P., Bernard, P., Litoux, P. & Dreno, B. (1996) Long-term interferon-alpha therapy induces autoantibodies against epidermis. Dermatology, 192, 50-55.
21. Gadol, N. & Ault, K.A. (1986) Phenotypic and functional characterization of human Leu1 (CD5) B cells. Immunological Review, 93, 23-34.
22. Granel, B., Bouabdallah, R., Serratrice, J., Swiader, L., Veit, V.V., Horschowski, N., Xerri, L., Disdier, P. & Weiller, P. (2001) Prelymphomatous presentation of T-cell non-Hodgkin lymphomas. A clinical and histopathological study of 11 cases. European Journal of Internal Medicine, 12, 57-59.
23. Gronbaek, K., D'amore, F. & Schmidt, K. (1995) Autoimmune phenomena in non-Hodgkin's lymphoma. Leukemia and Lymphoma, 18, 311-316.
24. Gronbaek, K., Straten, P.T., Ralfkiaer, E., Ahrenkiel, V., Andersen, M.K., Hansen, N.E., Zeuthen, J., Hou Jensen, K. & Guldberg, P. (1998) Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood, 92, 3018-3024.
25. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B. & Garter, K.C. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361-1392.
26. Hollingsworth, P.N., Dawkins, R.I. & Peter, J.B. (1996) Precise quantitation of antinuclear antibodies on HEp-2 cells without the need for serial dilution. Clinical and Diagnostic Laboratory Immunology, 3, 374-377.
27. Huminer, D., Tomer, Y., Pitlick, S. & Shoenfeld, Y. (1990) Autoantibodies in cancer patients: are they tumor related or age related. Autoimmunity, 5, 232-233.
28. Jonsson, V., Wiik, A., Hou-Jensen, K., Christiansen, M., Ryder, L.P., Madsen, H.O., Geisler, C., Hansen, M.M., Thomsen, K., Vorstrup, S. & Svejgaard, A. (1999) Autoimmunity and extranodal lymphocytic infiltrates in lymphoproliferative disorders. Journal of Internal Medicine, 245, 277-286.
29. Levine, A.M. (1994) Lymphoma complicating immunodeficiency disorders. Annals of Oncology, 5, 29-35.
30. McCurley, T.L., Collins, R.D., Ball, E. & Collins, R.D. (1990) Nodal and extranodal lymphoproliferative disorders in Sjogren's syndrome, a clinical and immunopathologic study. Human Pathology, 21, 482-492.
31. Mariette, X. (1999) Lymphomas in patients with Sjogren's syndrome: review of the literature and physiopathologic hypothesis. Leukemia and Lymphoma, 33, 93-99.
32. Mellemkjaer, L., Andersen, V., Liner, M.S., Grideley, G., Hoover, R. & Olsen, J.H. (1997) Non Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematous. Arthritis and Rheumatism, 40, 761-768.
33. Montenarh, M., Harlozinska, A., Bar, J.K., Kartarius, S., Gunther, J. & Sedlaczek, P. (1998) p53 autoantibodies in the sera, cyst and ascitic fluids of patients with ovarian cancer. International Journal of Oncology, 13, 605-610.
34. Ortiz-Hidalgo, C. & Wright, T.D. (1992) H. The morphological spectrum of monocytoid B-cell lymphoma and its relationship to lymphomas of mucosa-associated lymphoid tissue. Histopathology, 21, 555-561.
35. Pasquinelli, C., Bhavani, K. & Chisari, F.V. (1992) Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice. Cancer Research, 52, 2823-2829.
36. Penin, F., Godinot, C., Comte, J. & Gautheron, D.C. (1982) Vesicular preparation of a highly coupled ATPase-ATP synthase complex from pig heart mitochondria. Biochimica et Biophysica Acta, 679, 198-209.
37. Peterson, S.R., Talpur, R. & Duvic, M. (1998) Antinuclear antibody seropositivity in patients with cutaneous T-cell lymphoma. Journal of the American Academy of Dermatology, 39, 434-438.
38. Polliack, A. & Lugassy, G. (1992) Autoimmunity and autoimmune syndromes associated with and preceding the development of lymphoproliferative disorders. Leukemia, 6, 152-154.
39. Rattner, J.B., Rao, A., Fritzler, M.J., Valencia, D.W. & Yen, T.J. (1993) CENP-F is a 400 kDa kinetochore protein that exhibits a cell-cycle dependent localization. Cellular Motility Cytoskeleton, 26, 214-226.
40. Rattner, J.B., Rees, J., Whitehead, C.M., Casiano, C.A., Tan, E.M., Humbel, R.L., Conrad, K. & Fritzler, M.J. (1997) High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F. Clinical Investigation of Medicine, 20, 308-319.
41. Rattner, J.B., Mack, G.J. & Fritzler, M.J. (1998) Autoantibodies to components of the mitotic apparatus. Molecular Biology Reports, 25, 143-155.
42. Reeves, W.H. (2001) Tumor immunity and autoimmunity: a case of Dr Jekyll and Mr Hyde. Clinical Immunology, 100, 129-133.
43. Rodenburg, R.J., Raats, J.M., Pruijn, G.J. & Van Venrooij, W.J. (2000) Cell death: a trigger of autoimmunity. Bioassays, 22, 627-636.
44. Rovere, P., Fazzini, F., Sabbadini, M.G. & Manfredi, A.A. (2000) Apoptosis and systemic autoimmunity: the dendritic cell connection. European Journal of Histochemistry, 44, 229-236.
45. Rustin, M.H., Isenberg, D.A., Griffiths, M.H. & Gilkes, J.J. (1988) Sjogren's syndrome and pleomorphic T-cell lymphoma presenting with skin involvement. Journal of the Royal Society of Medicine, 81, 47-49.
46. Sallah, S., Sigounas, G., Vos, P., Wan, J.Y. & Nguyen, N.P. (2000) Autoimmune lymphocytic anemia in patients with non Hodgkin's lymphoma: characteristics and significance. Annals of Oncology, 11, 1571-1577.
47. Sato, S., Fujimoto, M., Ihn, H. & Takehara, K. (1994) Antibodies to centromere and centriole in scleroderma spectrum disorders. Dermatology, 189, 23-26.
48. Stockert, E., Jager, E., Chen, Y.T., Scanlan, M.J., Gout, I., Karbach, J., Arand, M., Knuth, A. & Old, L.J. (1998) A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. Journal of Experimental Medicine, 187, 1349-1354.
49. Swissa, M., Cohen, Y. & Schoenfeld, Y. (1992) Autoantibodies in the sera of patients with lymphoma. Leukemia and Lymphoma, 7, 117-122.
50. Syrigos, K.N., Charalambopoulos, A., Pliarchopoulou, K., Varsamidakis, N., Machairas, A. & Mandrekas, D. (2000) The prognostic significance of autoantibodies against dsDNA in patients with colorectal adenocarcinoma. Anticancer Research, 20, 4351-4353.
51. Tamura, K., Shimaoka, K. & Friedman, M. (1981) Thyroid abnormalities associated with treatment of malignant lymphoma. Cancer, 47, 2704-2711.
52. Timuragaoglu, A., Dumain, A., Ongut, G., Saka, O. & Karadogan, I. (2000) The significance of autoantibodies in non-Hodgkin's lymphoma. Leukemia and Lymphoma, 40, 119-122.
53. Tiplady, C.W., Hamilton, P.J. & Galloway, M.J. (2000) Acquired haemophilia complicating the remission of a patient with high grade non-Hodgkin's lymphoma treated by fludarabine. Clinical Laboratory Haematology, 22, 163-165.
54. Torchifin, V.P., Iakoubov, L.Z. & Estrov, Z. (2001) Antinuclear autoantibodies as potential antineoplastic agents. Trends in Immunology, 22, 424-427.
55. Tuffanelli, D.L., McKeon, F., Kleinsmith, D.M., Burnham, T.K. & Kirschner, M. (1983) Anticentromere and anticentriole antibodies in the scleroderma spectrum. Archives of Dermatology, 119, 560-566.
56. Tursi, A. & Gasbarrini, G. (1999) Acquired gastric mucosa-associated lymphoid tissue (MALT): a review with special emphasis on association with extragastric diseases and management problems of gastric MALT. Journal of Clinical Gastroenterology, 29, 133-137.
57. Wasserman, J., Glas, U. & Blomgren, H. (1975) Autoantibodies in patients with carcinoma of the breast. Correlation with prognosis. Clinical and Experimental Immunology, 19, 417-422.
58. Winter, S.F., Minna, J.D., Johnson, B.E., Takahashi, T., Gazdar, A.F. & Carbone, D.P. (1992) Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation. Cancer Research, 52, 4168-4174.
59. Xavier, R.M., Yamauchi, Y., Nakamura, M., Tanigawa, Y., Ishikura, H., Tsunematsu, T. & Kobayashi, S. (1995) Antinuclear antibodies in healthy aging people: a prospective study. Mechanisms of Ageing and Development, 78, 145-154.
60. Youinou, P., Mackenzie, L.E., Lamour, A., Magged R.A. & Lydyard, P.M. (1993) Human CD-positive b cells in lymphoid malignancy and connective tissue diseases. European Journal of Clinical Investigation, 23, 139-150.
61. Zhang, J.Y., Chan, E.K.L., Peng, X.X., Lu, M., Wang, X., Mueller, F. & Tan, E.M. (2001a) Autoimmune responses to mRNA binding proteins p62 and Kox in diverse malignancies. Clinical Immunology, 100, 149-156.
62. Zhang, J.Y., Zhu, W., Imai, H., Kiyosawa, K., Chan, E.K. & Tan, E.M. (2001b) De novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma. Clinical and Experimental Immunology, 125, 3-9.